Fengxun Biotechnology
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 4
About Fengxun Biotechnology
Founded in 2025 and based in Nantong, China, Fengxun Biotechnology focuses on advancing biotechnology research with applications in medical detection and inspection. The company develops innovative solutions to address healthcare testing needs by integrating biotechnology with applied science. The company provides research and development in biotechnology-driven testing technologies. Its work includes the development of inspection systems and related applications aimed at improving diagnostic accuracy, efficiency, and reliability across healthcare and biotechnology fields. The company generates revenue from biotechnology research services, medical testing technology development, and healthcare-related application solutions.
Who invested in Fengxun Biotechnology
4 investors across 1 round
See all investors in Fengxun Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 22, 2025
Amount
Undisclosed
Investors
Questions about Fengxun Biotechnology
Who invested in Fengxun Biotechnology?
Fengxun Biotechnology has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fengxun Biotechnology raised?
Fengxun Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fengxun Biotechnology last raise money?
Fengxun Biotechnology's most recent round on record is a Series A, in Sep 2025.
What does Fengxun Biotechnology do?
Founded in 2025 and based in Nantong, China, Fengxun Biotechnology focuses on advancing biotechnology research with applications in medical detection and inspection.
Where is Fengxun Biotechnology headquartered?
Fengxun Biotechnology is headquartered in Nantong, China.
Which VCs invest in companies like Fengxun Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Fengxun Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Fengxun Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.